These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Biological characteristics of dengue virus and potential targets for drug design. Qi RF; Zhang L; Chi CW Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):91-101. PubMed ID: 18235970 [TBL] [Abstract][Full Text] [Related]
6. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin. Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141 [TBL] [Abstract][Full Text] [Related]
7. Antiviral Role of Phenolic Compounds against Dengue Virus: A Review. Loaiza-Cano V; Monsalve-Escudero LM; Filho CDSMB; Martinez-Gutierrez M; Sousa DP Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33374457 [TBL] [Abstract][Full Text] [Related]
8. An inducible heat shock protein 70 small molecule inhibitor demonstrates anti-dengue virus activity, validating Hsp70 as a host antiviral target. Howe MK; Speer BL; Hughes PF; Loiselle DR; Vasudevan S; Haystead TA Antiviral Res; 2016 Jun; 130():81-92. PubMed ID: 27058774 [TBL] [Abstract][Full Text] [Related]
9. The search for nucleoside/nucleotide analog inhibitors of dengue virus. Chen YL; Yokokawa F; Shi PY Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002 [TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication. Panda K; Alagarasu K; Parashar D Molecules; 2021 Feb; 26(4):. PubMed ID: 33670247 [TBL] [Abstract][Full Text] [Related]
12. Drug repurposing approaches to fight Dengue virus infection and related diseases. Botta L; Rivara M; Zuliani V; Radi M Front Biosci (Landmark Ed); 2018 Jan; 23(6):997-1019. PubMed ID: 28930586 [TBL] [Abstract][Full Text] [Related]
13. Strategies for the treatment of dengue virus infections: a narrative account. De Clercq E Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010 [TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys. Farias KJ; Machado PR; Muniz JA; Imbeloni AA; da Fonseca BA Viral Immunol; 2015 Apr; 28(3):161-9. PubMed ID: 25664975 [TBL] [Abstract][Full Text] [Related]
15. An iminosugar with potent inhibition of dengue virus infection in vivo. Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501 [TBL] [Abstract][Full Text] [Related]
17. Tatanan A from the Acorus calamus L. root inhibited dengue virus proliferation and infections. Yao X; Ling Y; Guo S; Wu W; He S; Zhang Q; Zou M; Nandakumar KS; Chen X; Liu S Phytomedicine; 2018 Mar; 42():258-267. PubMed ID: 29655694 [TBL] [Abstract][Full Text] [Related]
18. Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein. Saraiva RG; Fang J; Kang S; Angleró-Rodríguez YI; Dong Y; Dimopoulos G PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006443. PubMed ID: 29694346 [TBL] [Abstract][Full Text] [Related]
19. Effects of ribavirin and hydroxyurea on oral infection of Aedes aegypti (L.) with dengue virus. Lee HL; Phong TV; Rohani A Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1358-64. PubMed ID: 23413698 [TBL] [Abstract][Full Text] [Related]
20. Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures. Duran A; Valero N; Mosquera J; Fuenmayor E; Alvarez-Mon M Life Sci; 2017 Dec; 191():180-185. PubMed ID: 29055802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]